Edition:
India

Melinta Therapeutics Q3 Loss Per Share $0.50


Wednesday, 7 Nov 2018 

Nov 7 (Reuters) - Melinta Therapeutics Inc ::MELINTA THERAPEUTICS REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.50.Q3 EARNINGS PER SHARE VIEW $-0.94 -- THOMSON REUTERS I/B/E/S.MELINTA THERAPEUTICS INC - IMPLEMENTED COST REDUCTION INITIATIVES TO REDUCE OPERATING EXPENSES BY MORE THAN $50 MILLION IN 2019.MELINTA THERAPEUTICS INC - QTRLY TOTAL REVENUE $34.1 MILLION VERSUS $3.2 MILLION. 

Company Quote

4.79
0.2 +4.36%
1:30am IST